IMS site is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
7th-8th Nov, 2019 Sofitel, New York
Senior Director, Patent Attorney,Administration & Management - LegalGlenmark Pharmaceuticals Ltd.
Partner and Litigation Department Co-ChairCantor Colburn
Partner and Co-Chair of the Intellectual Property Practice GroupGoldberg Segalla
Senior Director, Patent Attorney,Administration & Management - Legal
Glenmark Pharmaceuticals Ltd.
Partner and Litigation Department Co-Chair
Steve Coyle is a Partner and co-chairs the firm's Litigation Department. He is a
trial lawyer with more than 20 years' experience in litigating and trying
complex disputed matters, and he has specialized in patent and all varieties of
intellectual property litigation for the past 15 years. Steve’s areas of focus
include ANDA and Hatch-Waxman litigation, where he has represented the
rights of generic drug manufacturers and helped them to bring products to
market. He is also the Chair of Cantor Colburn’s Pharmaceutical Litigation
Practice. Steve represents clients as both plaintiffs and defendants in a variety
of other patent matters, involving such diverse technologies as software,
cybersecurity, fiber optics, induction lighting, microwave circuit boards, robotic
measurement equipment, media packaging, flexible gas piping, and
telecommunications. Steve has substantial experience litigating trademark,
copyright, and trade secret matters as well. He has tried and litigated patent
and other intellectual property cases throughout the country, and he has
represented clients in alternative dispute resolution forums such as arbitrations
and mediations. Steve has also handled multiple appeals, including before the
Federal Circuit. In all of his cases, Steve strives to develop and follow a
pragmatic strategy that advances not only his clients’ short term litigation goals
but also their long term business needs.
Partner and Co-Chair of the Intellectual Property Practice Group
Ron Daignault, partner and co-chair of Goldberg Segalla's Intellectual Property Practice, is a trial attorney with over 25 years of experience and an intellectual property litigator. Widely respected as a pharmaceutical Hatch-Waxman and Abbreviated New Drug Application (ANDA) litigator for both generic and branded drug companies, Ron has guided clients through litigation involving dozens of patents, products, formulations and designs, and methods of use. Ron has been involved in numerous bench and jury trials and evidentiary hearings, serving as lead counsel or second chair in most of them, and has also argued before several U.S. Courts of Appeals and the New York State Appellate Division.
A frequent writer and speaker on topics in the field of intellectual property, Ron has held a spot on the New York Metro Super Lawyers list consistently since 2012, and Managing Intellectual Property has recognized him as a “Star” in both Life Sciences and Intellectual Property every year since 2013. He currently serves as an Advisory Board member of Bloomberg/BNA's Life Sciences Law and Industry Report and an Amicus Committee member of the New York Intellectual Property Law Association.